国际流行病学传染病学杂志
國際流行病學傳染病學雜誌
국제류행병학전염병학잡지
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY AND INFECTIOUS DISEASE
2014年
1期
6-10
,共5页
姜云水%李剑波%顾春燕%陈科达%唐彩华%包佳源%毛岱敏%张峰%庄昉成
薑雲水%李劍波%顧春燕%陳科達%唐綵華%包佳源%毛岱敏%張峰%莊昉成
강운수%리검파%고춘연%진과체%당채화%포가원%모대민%장봉%장방성
细胞培养技术%微载体%高密度培养%MRC-5细胞
細胞培養技術%微載體%高密度培養%MRC-5細胞
세포배양기술%미재체%고밀도배양%MRC-5세포
Cell culture techniques%Microcarrier%High density cultivation%MRC-5 cell
目的 通过探索MRC-5细胞的微载体培养条件,以期建立MRC-5细胞的高密度培养方法.方法 用3种不同培养基(MEM、M199、DMEM)分别培养3.0×104/mL的MRC-5细胞,观察它们的细胞增殖及传代能力;在Spinner培养系统中,用1.0 g/L Cytopore 2和3.0 g/L Cytodex 3分别培养密度为3.70× 105/mL和2.98×105/mL的MRC-5细胞,观察两种载体对细胞生长代谢和细胞密度的影响,筛选出最适宜的培养基及微载体.使用5 L CelliGen310生物反应器对筛选获得的培养基及微载体进行MRC-5细胞的灌流培养初步摸索.结果 MRC-5细胞在MEM、M199、DMEM培养基中培养96 h细胞分别增殖了7.0、4.4和3.0倍;在MEM培养基中连续传代至5次以上,细胞增殖稳定,1:3传代72 h形成致密单层,而在M199和DMEM培养基中连续传代均未能获得理想的细胞形态.经96~120 h的培养后,使用1.0 g/L Cytopore 2培养的MRC-5细胞密度达到2.20× 106/mL高于使用3.0 g/L Cytodex 3的1.12×106/mL,且前者葡萄糖和乳酸代谢较后者更为活跃.首选MEM和Cytopore 2作为MRC-5细胞的灌流培养体系.在5L生物反应器中以1.0 g/L Cytopore 2和2.5LMEM培养基培养MRC-5细胞至144h,细胞密度达到1.54×106/mL.结论 初步建立的MEM Cytopore 2微载体细胞培养方法能够获得高密度、活性良好的MRC-5传代细胞.
目的 通過探索MRC-5細胞的微載體培養條件,以期建立MRC-5細胞的高密度培養方法.方法 用3種不同培養基(MEM、M199、DMEM)分彆培養3.0×104/mL的MRC-5細胞,觀察它們的細胞增殖及傳代能力;在Spinner培養繫統中,用1.0 g/L Cytopore 2和3.0 g/L Cytodex 3分彆培養密度為3.70× 105/mL和2.98×105/mL的MRC-5細胞,觀察兩種載體對細胞生長代謝和細胞密度的影響,篩選齣最適宜的培養基及微載體.使用5 L CelliGen310生物反應器對篩選穫得的培養基及微載體進行MRC-5細胞的灌流培養初步摸索.結果 MRC-5細胞在MEM、M199、DMEM培養基中培養96 h細胞分彆增殖瞭7.0、4.4和3.0倍;在MEM培養基中連續傳代至5次以上,細胞增殖穩定,1:3傳代72 h形成緻密單層,而在M199和DMEM培養基中連續傳代均未能穫得理想的細胞形態.經96~120 h的培養後,使用1.0 g/L Cytopore 2培養的MRC-5細胞密度達到2.20× 106/mL高于使用3.0 g/L Cytodex 3的1.12×106/mL,且前者葡萄糖和乳痠代謝較後者更為活躍.首選MEM和Cytopore 2作為MRC-5細胞的灌流培養體繫.在5L生物反應器中以1.0 g/L Cytopore 2和2.5LMEM培養基培養MRC-5細胞至144h,細胞密度達到1.54×106/mL.結論 初步建立的MEM Cytopore 2微載體細胞培養方法能夠穫得高密度、活性良好的MRC-5傳代細胞.
목적 통과탐색MRC-5세포적미재체배양조건,이기건립MRC-5세포적고밀도배양방법.방법 용3충불동배양기(MEM、M199、DMEM)분별배양3.0×104/mL적MRC-5세포,관찰타문적세포증식급전대능력;재Spinner배양계통중,용1.0 g/L Cytopore 2화3.0 g/L Cytodex 3분별배양밀도위3.70× 105/mL화2.98×105/mL적MRC-5세포,관찰량충재체대세포생장대사화세포밀도적영향,사선출최괄의적배양기급미재체.사용5 L CelliGen310생물반응기대사선획득적배양기급미재체진행MRC-5세포적관류배양초보모색.결과 MRC-5세포재MEM、M199、DMEM배양기중배양96 h세포분별증식료7.0、4.4화3.0배;재MEM배양기중련속전대지5차이상,세포증식은정,1:3전대72 h형성치밀단층,이재M199화DMEM배양기중련속전대균미능획득이상적세포형태.경96~120 h적배양후,사용1.0 g/L Cytopore 2배양적MRC-5세포밀도체도2.20× 106/mL고우사용3.0 g/L Cytodex 3적1.12×106/mL,차전자포도당화유산대사교후자경위활약.수선MEM화Cytopore 2작위MRC-5세포적관류배양체계.재5L생물반응기중이1.0 g/L Cytopore 2화2.5LMEM배양기배양MRC-5세포지144h,세포밀도체도1.54×106/mL.결론 초보건립적MEM Cytopore 2미재체세포배양방법능구획득고밀도、활성량호적MRC-5전대세포.
Objective To create a high density MRC-5 cell culture method by exploring the microcarrierbased cell culture conditions.Methods MRC-5 cells (3.0×104/mL) were cultured in three different media (MEM,M199,DMEM) and their proliferation and passage capacity were observed.In Spinner culture system,MRC-5 cells were cultured at the density of 3.70×105/mL and 2.98×105/mL with 1.0 g/L Cytopore 2 and 3.0 g/L Cytodex 3 microcarriers,respectively.The effect of the two microcarriers on cell growth,metabolism and cell density was recorded to screen out the most appropriate medium and microcarrier.The 5 L CelliGen310 bioreactor was used to explore the MRC-5 perfusion culture condition by the established medium and microcarrier.Results After 96 h cultured in MEM,M199 and DMEM media,MRC-5 cells were proliferated 7.0,4.4,and 3.0 times,respectively.MRC-5 cells cultured in MEM medium generated more than 5 passages and formed dense monolayer after 72 h with passage ratio 1:3,while MRC-5 cells in M199 and DMEM media failed to obtain the ideal cell morphology during the passage.After 96-120 h cultured in Spinner system,the concentration of MRC-5 cells in 1.0 g/L Cytopore2 was higher than that in 3.0 g/L Cydodex3 (2.20×106/mL vs 1.12×106/mL),with more active metabolism of glucose and lactic acid.MEM and Cytopore2 were selected as the MRC-5 perfusion culture system.The concentration of MRC-5 cells reached 1.54×106/mL when cultured with 1.0 g/L Cytopore2 and 2.5 L MEM in 5 L bioreactor for 144 h.Conclusions The initial establishment of cell culture method based on Cytopore 2 microcarrier and MEM medium can obtain high density MRC-5 passage cells with good viability.